The effect of combined with aripiprazole to improve hyperprolactinemia caused by antipsychotic drugs
10.3760/cma.j.issn.1008-6706.2015.08.023
- VernacularTitle:联用阿立哌唑对改善抗精神病药物所致高催乳激素血症的疗效
- Author:
Yuefeng WANG
;
Binjun LV
;
Enbiao HE
- Publication Type:Journal Article
- Keywords:
Aripiprazole;
Psychotropic Drugs;
Schizophrenia;
Hyperprolactinemia
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;(8):1187-1189
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy and safety of combined with aripiprazole to improve hyper-prolactinemia caused by antipsychotic drugs.Methods 70 patients with schizophrenia who had been treated with antipsychotic drugs for 4 weeks prior to the study were divided into the two groups by random number table method:the treatment group(35 cases)were given each additionally 2.5 mg of aripiprazole oral,one time every day.The con-trol group (35 cases)continued with no extra management.The treatment group on the basis of the original drug administered daily in combination with aripiprazole 2.5mg,the control group maintained the previous drug treatment. Serum prolactin concentrations were assayed in patients of both groups before treatment and after 4 weeks treatment. At the same time,used the positive and negative symptom scale (PANSS)to assess the state of the clinical symptoms. The side effects were evaluated by Treatment Emergent Symptom Scale(TESS).Results After combined with aripi-prazole,it demonstrated that serum prolactin level in patients of the treatment group were significantly lowered [(78.64 ±30.15)μg/L vs (35.01 ±13.99)μg/L,t=9.585,P<0.05],while those in patients of the control group had no change[(80.34 ±46.08)μg/L vs (79.94 ±43.84)μg/L,t=0.084,P>0.05].There were no significant differences between the two groups of PANSS and TESS scores(all P>0.05 ).Conclusion Combined with aripi-prazole for antipsychotic-induced hyperprolactinemia have a therapeutic effect and relatively safe.
